U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 14:55:16 UTC 2023
Edited
by admin
on Sat Dec 16 14:55:16 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
3062P60MH9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPRATUZUMAB
INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
EPRATUZUMAB [MART.]
Common Name English
EPRATUZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
LYMPHOCIDE
Brand Name English
IMMU-HLL2
Code English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
HLL2
Code English
IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
AMG-412
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
EPRATUZUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER
Common Name English
Epratuzumab [WHO-DD]
Common Name English
epratuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 260908
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
FDA ORPHAN DRUG 113298
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
Code System Code Type Description
EVMPD
SUB31567
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
NCI_THESAURUS
C1887
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
ChEMBL
CHEMBL2108404
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
DRUG BANK
DB04958
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
USAN
KK-47
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
WIKIPEDIA
Epratuzumab
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
INN
7920
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
CAS
205923-57-5
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
MERCK INDEX
m4957
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY Merck Index
FDA UNII
3062P60MH9
Created by admin on Sat Dec 16 14:55:17 UTC 2023 , Edited by admin on Sat Dec 16 14:55:17 UTC 2023
PRIMARY
From To
1_22 1_96
1_143 1_199
1_219 3_219
1_225 2_225
1_228 2_228
1_260 1_320
1_366 1_424
2_22 2_96
2_143 2_199
2_219 4_219
2_260 2_320
2_366 2_424
3_23 3_94
3_139 3_199
4_23 4_94
4_139 4_199
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
B-CELL RECEPTOR CD22
TARGET -> INHIBITOR
YTTRIUM Y-90 EPRATUZUMAB TETRAXETAN
PARENT -> DERIVATIVE
test
YTTRIUM Y-90 EPRATUZUMAB
INGREDIENT -> STARTING MATERIAL
Related Record Type Details
EPRATUZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966